Above Inc.
PrivateLast Round
Seed
Nov 19, 2025
Total Funding Raised
$700,000
Company Overview
Above Inc. is a healthcare technology company that provides a platform for allergy and asthma management through AI-powered diagnostics, smart medical devices, and personalized treatment plans.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Medical Devices, Medical AI, Health IoT, Patient Engagement
Business Model
B2C
Customer Profile
Hardware + Subscription, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Above Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Above Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 19, 2025 |
Above Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cake Ventures | Seed |
| Long Journey Ventures | Seed |
| Hustle Fund | Seed |
Above Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Above Inc.'s valuation, stock price, and market status.